158 related articles for article (PubMed ID: 30831024)
1. A High-Throughput Glycosyltransferase Inhibition Assay for Identifying Molecules Targeting Fucosylation in Cancer Cell-Surface Modification.
Zhang X; Chen F; Petrella A; Chacón-Huete F; Covone J; Tsai TW; Yu CC; Forgione P; Kwan DH
ACS Chem Biol; 2019 Apr; 14(4):715-724. PubMed ID: 30831024
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic Synthesis of a Fluorogenic Reporter Substrate and the Development of a High-Throughput Assay for Fucosyltransferase VIII Provide a Toolkit to Probe and Inhibit Core Fucosylation.
Soroko M; Kwan DH
Biochemistry; 2020 Jun; 59(22):2100-2110. PubMed ID: 32441090
[TBL] [Abstract][Full Text] [Related]
3. Array-assisted characterization of a fucosyltransferase required for the biosynthesis of complex core modifications of nematode N-glycans.
Yan 闫石 S; Serna S; Reichardt NC; Paschinger K; Wilson IBH
J Biol Chem; 2013 Jul; 288(29):21015-21028. PubMed ID: 23754284
[TBL] [Abstract][Full Text] [Related]
4. Metabolic inhibition of sialyl-Lewis X biosynthesis by 5-thiofucose remodels the cell surface and impairs selectin-mediated cell adhesion.
Zandberg WF; Kumarasamy J; Pinto BM; Vocadlo DJ
J Biol Chem; 2012 Nov; 287(47):40021-30. PubMed ID: 23019334
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs.
Cheng L; Gao S; Song X; Dong W; Zhou H; Zhao L; Jia L
Oncotarget; 2016 Sep; 7(38):61199-61214. PubMed ID: 27533464
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and analysis of potential α1,3-fucosyltransferase inhibitors.
Seelhorst K; Piernitzki T; Lunau N; Meier C; Hahn U
Bioorg Med Chem; 2014 Nov; 22(22):6430-7. PubMed ID: 25438767
[TBL] [Abstract][Full Text] [Related]
7. Fucosylation in Urological Cancers.
Fujita K; Hatano K; Hashimoto M; Tomiyama E; Miyoshi E; Nonomura N; Uemura H
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948129
[TBL] [Abstract][Full Text] [Related]
8. Detecting substrate glycans of fucosyltransferases with fluorophore-conjugated fucose and methods for glycan electrophoresis.
Wu ZL; Whittaker M; Ertelt JM; Person AD; Kalabokis V
Glycobiology; 2020 Dec; 30(12):970-980. PubMed ID: 32248235
[TBL] [Abstract][Full Text] [Related]
9. β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma.
Chandler KB; Alamoud KA; Stahl VL; Nguyen BC; Kartha VK; Bais MV; Nomoto K; Owa T; Monti S; Kukuruzinska MA; Costello CE
Mol Omics; 2020 Jun; 16(3):195-209. PubMed ID: 32203567
[TBL] [Abstract][Full Text] [Related]
10. Toward α-1,3/4 fucosyltransferases targeted drug discovery: In silico uncovering of promising natural inhibitors of fucosyltransferase 6.
Magdaleno JSL; Grewal RK; Medina-Franco JL; Oliva R; Shaikh AR; Cavallo L; Chawla M
J Cell Biochem; 2023 Aug; 124(8):1173-1185. PubMed ID: 37357420
[TBL] [Abstract][Full Text] [Related]
11. Enzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in Cancer.
Kizuka Y; Taniguchi N
Biomolecules; 2016 Apr; 6(2):. PubMed ID: 27136596
[TBL] [Abstract][Full Text] [Related]
12. A miniaturized high-throughput screening assay for fucosyltransferase VII.
Ahsen Ov; Voigtmann U; Klotz M; Nifantiev N; Schottelius A; Ernst A; Müller-Tiemann B; Parczyk K
Anal Biochem; 2008 Jan; 372(1):96-105. PubMed ID: 17923099
[TBL] [Abstract][Full Text] [Related]
13. An Alkynyl-Fucose Halts Hepatoma Cell Migration and Invasion by Inhibiting GDP-Fucose-Synthesizing Enzyme FX, TSTA3.
Kizuka Y; Nakano M; Yamaguchi Y; Nakajima K; Oka R; Sato K; Ren CT; Hsu TL; Wong CH; Taniguchi N
Cell Chem Biol; 2017 Dec; 24(12):1467-1478.e5. PubMed ID: 29033318
[TBL] [Abstract][Full Text] [Related]
14. Sialyl Lewis(x) epitopes do not occur on acute phase proteins in mice: relationship to the absence of alpha3-fucosyltransferase in the liver.
Havenaar EC; Hoff RC; van den Eijnden DH; van Dijk W
Glycoconj J; 1998 Apr; 15(4):389-95. PubMed ID: 9613826
[TBL] [Abstract][Full Text] [Related]
15. Fucosylation in cancer biology and its clinical applications.
Shan M; Yang D; Dou H; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():93-119. PubMed ID: 30905466
[TBL] [Abstract][Full Text] [Related]
16. Biological function of fucosylation in cancer biology.
Miyoshi E; Moriwaki K; Nakagawa T
J Biochem; 2008 Jun; 143(6):725-9. PubMed ID: 18218651
[TBL] [Abstract][Full Text] [Related]
17. Fucosylated Antigens in Cancer: An Alliance toward Tumor Progression, Metastasis, and Resistance to Chemotherapy.
Blanas A; Sahasrabudhe NM; Rodríguez E; van Kooyk Y; van Vliet SJ
Front Oncol; 2018; 8():39. PubMed ID: 29527514
[TBL] [Abstract][Full Text] [Related]
18. FRET-based direct and continuous monitoring of human fucosyltransferases activity: an efficient synthesis of versatile GDP-L-fucose derivatives from abundant D-galactose.
Maeda T; Nishimura S
Chemistry; 2008; 14(2):478-87. PubMed ID: 17929334
[TBL] [Abstract][Full Text] [Related]
19. Suppressors of alpha(1,3)fucosylation identified by expression cloning in the LEC11B gain-of-function CHO mutant.
Chen W; Tang J; Stanley P
Glycobiology; 2005 Mar; 15(3):259-69. PubMed ID: 15525819
[TBL] [Abstract][Full Text] [Related]
20. Altered fucosyltransferase expression in the superior temporal gyrus of elderly patients with schizophrenia.
Mueller TM; Yates SD; Haroutunian V; Meador-Woodruff JH
Schizophr Res; 2017 Apr; 182():66-73. PubMed ID: 27773385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
